Option chain shows key data for Nuveen Churchill Direct's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Nuveen Churchill Direct.

Nuveen Churchill Direct (NYSE:NCDL) Stock, Option Chain

Nuveen Churchill Direct

Nuveen Churchill Direct Lending Corp is a specialty finance company focused predominantly on investing in senior secured loans to private equity-owned U.S. middle market companies. It invest in senior secured loans that typically pay floating interest rates and are senior in the capital structure to junior debt and equity.

Long Ideas

News

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

KALV

NCDL

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Nuveen Churchill Direct Lending Corp. Common Stock

Nuveen Churchill Direct Lending Corp

<p>The Q4 earnings report for <strong>Mid-America Apartment</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) was released on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Mid-America Apartment missed estimated earnings by -0.0%, reporting an EPS of $2.23 versus an estimate of $2.24.</p>
<p>Revenue was up $7.58 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>The company beat on EPS by $0.03 in the last quarter, resulting in a 1.0% drop share price change the following day.</p>
<p>Here's a look at Mid-America Apartment's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.18</td>
<td>2.20</td>
<td>2.22</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.21</td>
<td>2.22</td>
<td>2.22</td>
<td>2.32</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>549.38M</td>
<td>545.41M</td>
<td>542.72M</td>
<td>542.77M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>551.13M</td>
<td>546.43M</td>
<td>543.62M</td>
<td>542.25M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Mid-America Apartment management provided guidance for Q1 2025, expecting earnings between $2.08 and $2.24 per share.</p>
<p>To track all earnings releases for Mid-America Apartment <a href="https://www.benzinga.com/quote/MAA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

Mid-America Apartment Earnings Report: Q4 Overview

<p>KOMET-001 registrational trial in R/R NPM1-m AML achieved primary CR/CRh endpoint; topline data submitted for presentation at an upcoming medical meeting –</p>
<p>– NDA submission for ziftomenib on track for 2Q 2025 –</p>
<p>– Registrational KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated approval and full approval –</p>
<p>– Registrational KOMET-017-NIC trial of venetoclax / azacitidine combination will assess CR and OS as dual-primary endpoints to support potential U.S. accelerated approval and full approval –</p>
<p>– KOMET-017-IC and NIC Phase 3 trials expected to initiate in 2H 2025 –</p>
<p>– Multiple clinical data presentations for ziftomenib and pipeline programs anticipated throughout 2025 –</p>


Biotech

General

KURA

Kura Oncology And Kyowa Kirin Announce Ziftomenib Monotherapy Registrational Trial And FDA Feedback For Upcoming Frontline Combination Trial Designs

<p><strong>Lesaka Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSAK#NASDAQ">LSAK</a>) just disclosed its Q2 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Lesaka Technologies missed estimated earnings by 0.0%, reporting an EPS of $0.01 versus an estimate of $0.01.</p>
<p>Revenue was up $2.92 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>During the previous quarter, the company beat on EPS by $0.08, leading to a 3.0% drop share price change the next day.</p>
<p>Here's a look at Lesaka Technologies's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.04</td>
<td>0.02</td>
<td>0.02</td>
<td>0.01</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>144.16M</td>
<td>149.30M</td>
<td>145.53M</td>
<td>144.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>145.55M</td>
<td>146.05M</td>
<td>138.19M</td>
<td>143.89M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Lesaka Technologies <a href="https://www.benzinga.com/quote/LSAK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LSAK

Insights into Lesaka Technologies Q2 Earnings

<p><strong>Paycor HCM</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) released its Q2 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Paycor HCM beat estimated earnings by 17.0%, reporting an EPS of $0.14 versus an estimate of $0.12.</p>
<p>Revenue was up $20.90 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company beat on EPS by $0.02 which was followed by a 3.0% increase in the share price the next day.</p>
<p>Here's a look at Paycor HCM's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.08</td>
<td>0.09</td>
<td>0.20</td>
<td>0.09</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.10</td>
<td>0.11</td>
<td>0.21</td>
<td>0.11</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>162.17M</td>
<td>161.17M</td>
<td>186.44M</td>
<td>155.59M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>167.48M</td>
<td>164.80M</td>
<td>187.02M</td>
<td>159.54M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Paycor HCM <a href="https://www.benzinga.com/quote/PYCR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PYCR

Paycor HCM Earnings Report: Q2 Overview

<p><strong>News</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWSA#NASDAQ">NWSA</a>) announced its Q2 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>News beat estimated earnings by 3.0%, reporting an EPS of $0.33 versus an estimate of $0.32.</p>
<p>Revenue was down $348.00 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>During the previous quarter, the company beat on EPS by $0.05, leading to a 1.0% increase share price change the next day.</p>
<p>Here's a look at News's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.16</td>
<td>0.14</td>
<td>0.11</td>
<td>0.19</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.21</td>
<td>0.17</td>
<td>0.11</td>
<td>0.26</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.56B</td>
<td>2.47B</td>
<td>2.46B</td>
<td>2.55B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.58B</td>
<td>2.58B</td>
<td>2.42B</td>
<td>2.59B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for News <a href="https://www.benzinga.com/quote/NWSA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


NWSA

Earnings Breakdown: News Q2

<p>Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $0.48 by 145.83 percent. This is a 2066.67 percent increase over losses of $(0.06) per share from the same period last year.  The company reported quarterly sales of $438.72 million which beat the analyst consensus estimate of $340.62 million by 28.80 percent.  This is a 104.17 percent increase over sales of $214.88 million the same period last year.</p>


Earnings Beats

Moelis Q4 Adj EPS $1.18 Beats $0.48 Estimate, Sales $438.72M Beat $340.62M Estimate

<p><strong>Rayonier</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYN#NYSE">RYN</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:20 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Rayonier beat estimated earnings by 35.0%, reporting an EPS of $0.27 versus an estimate of $0.2.</p>
<p>Revenue was up $258.90 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company missed on EPS by $0.01 in the previous quarter, leading to a 1.0% increase share price change the next day.</p>
<p>Here's a look at Rayonier's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.13</td>
<td>0.13</td>
<td>0.04</td>
<td>0.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.12</td>
<td>0.02</td>
<td>0.05</td>
<td>0.17</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>210.86M</td>
<td>220.04M</td>
<td>193.67M</td>
<td>229.75M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>195.00M</td>
<td>173.60M</td>
<td>168.10M</td>
<td>467.40M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Rayonier management provided guidance for FY 2025, expecting earnings between $0.51 and $0.64 per share.</p>
<p>To track all earnings releases for Rayonier <a href="https://www.benzinga.com/quote/RYN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Rayonier Q4 Earnings Summary & Key Takeaways

<p><strong>LiveRamp Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAMP#NYSE">RAMP</a>) announced its Q3 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>LiveRamp Holdings beat estimated earnings by 20.0%, reporting an EPS of $0.55 versus an estimate of $0.46.</p>
<p>Revenue was up $21.54 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.14 in the last quarter, resulting in a 8.0% increase share price change the following day.</p>
<p>Here's a look at LiveRamp Holdings's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.37</td>
<td>0.31</td>
<td>0.19</td>
<td>0.40</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.51</td>
<td>0.35</td>
<td>0.25</td>
<td>0.47</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>176.04M</td>
<td>171.91M</td>
<td>160.62M</td>
<td>172.54M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>154.07M</td>
<td>175.96M</td>
<td>171.85M</td>
<td>173.87M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for LiveRamp Holdings <a href="https://www.benzinga.com/quote/RAMP/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


RAMP

Earnings Summary: LiveRamp Holdings Q3

<p>The Q4 earnings report for <strong>Regional Mgmt</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RM#NYSE">RM</a>) was released on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Regional Mgmt beat estimated earnings by 10.0%, reporting an EPS of $0.98 versus an estimate of $0.89.</p>
<p>Revenue was up $13.17 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.29 in the last quarter, resulting in a 6.0% drop share price change the following day.</p>
<p>Here's a look at Regional Mgmt's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.05</td>
<td>0.58</td>
<td>0.88</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.76</td>
<td>0.86</td>
<td>1.56</td>
<td>0.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>144.37M</td>
<td>138.83M</td>
<td>139.58M</td>
<td>141.95M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>146.34M</td>
<td>143.03M</td>
<td>144.31M</td>
<td>141.66M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Regional Mgmt <a href="https://www.benzinga.com/quote/RM/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Regional Mgmt Q4 Earnings Report: What Investors Need to Know

<p>The Q3 earnings report for <strong>ARM Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) was released on Wednesday, February 5, 2025 at 04:04 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>ARM Holdings beat estimated earnings by 15.0%, reporting an EPS of $0.39 versus an estimate of $0.34.</p>
<p>Revenue was up $159.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.04, leading to a 4.0% increase share price change the next day.</p>
<p>Here's a look at ARM Holdings's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.26</td>
<td>0.34</td>
<td>0.30</td>
<td>0.25</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.30</td>
<td>0.40</td>
<td>0.36</td>
<td>0.29</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>808.37M</td>
<td>903.57M</td>
<td>875.62M</td>
<td>761.62M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>844.00M</td>
<td>939.00M</td>
<td>928.00M</td>
<td>824.00M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>ARM Holdings management provided guidance for Q4 2025, expecting earnings between $0.48 and $0.56 per share.</p>
<p>To track all earnings releases for ARM Holdings <a href="https://www.benzinga.com/quote/ARM/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ARM Holdings Earnings Report: Q3 Overview

<p><strong>Safehold</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Safehold missed estimated earnings by -3.0%, reporting an EPS of $0.36 versus an estimate of $0.37.</p>
<p>Revenue was down $11.13 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.0 in the last quarter, resulting in a 4.0% drop share price change the following day.</p>
<p>Here's a look at Safehold's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.37</td>
<td>0.36</td>
<td>0.39</td>
<td>0.35</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.37</td>
<td>0.41</td>
<td>0.43</td>
<td>0.36</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>90.41M</td>
<td>88.19M</td>
<td>88.08M</td>
<td>85.95M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>90.70M</td>
<td>89.89M</td>
<td>93.21M</td>
<td>103.00M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Safehold <a href="https://www.benzinga.com/quote/SAFE/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SAFE

Safehold Q4 Earnings Assessment

WIIM

QCOM

Qualcomm shares are trading lower. The company reported Q1 financial results.

<p>The earnings results for <strong>Coherent</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) for Q2 were made public on Wednesday, February 5, 2025 at 04:14 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Coherent beat estimated earnings by 42.0%, reporting an EPS of $0.95 versus an estimate of $0.67.</p>
<p>Revenue was up $304.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>During the previous quarter, the company beat on EPS by $0.13, leading to a 10.0% increase share price change the next day.</p>
<p>Here's a look at Coherent's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.61</td>
<td>0.59</td>
<td>0.42</td>
<td>0.26</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.74</td>
<td>0.61</td>
<td>0.53</td>
<td>0.36</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.31B</td>
<td>1.28B</td>
<td>1.17B</td>
<td>1.12B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.35B</td>
<td>1.31B</td>
<td>1.21B</td>
<td>1.13B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Coherent management provided guidance for Q3 2025, expecting earnings between $0.75 and $0.95 per share.</p>
<p>To track all earnings releases for Coherent <a href="https://www.benzinga.com/quote/COHR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


COHR

Earnings Breakdown: Coherent Q2

<p><strong>Unifi</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UFI#NYSE">UFI</a>) released its Q2 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Unifi missed estimated earnings by -56.00000000000001%, reporting an EPS of $-0.86 versus an estimate of $-0.55.</p>
<p>Revenue was up $1.96 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>During the previous quarter, the company missed on EPS by $0.17, leading to a 11.0% drop share price change the next day.</p>
<p>Here's a look at Unifi's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.25</td>
<td>-0.21</td>
<td>-0.42</td>
<td>-0.85</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.42</td>
<td>-0.22</td>
<td>-0.57</td>
<td>-0.81</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>148.01M</td>
<td>162.00M</td>
<td>151.13M</td>
<td>135.57M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>147.37M</td>
<td>157.45M</td>
<td>149.00M</td>
<td>136.92M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Unifi <a href="https://www.benzinga.com/quote/UFI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Unifi Q2 Earnings Report: What Investors Need to Know

<p>The earnings results for <strong>First Industrial Realty</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:28 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>First Industrial Realty beat estimated earnings by 3.0%, reporting an EPS of $0.71 versus an estimate of $0.69.</p>
<p>Revenue was up $18.31 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>The company beat on EPS by $0.01 in the last quarter, resulting in a 2.0% drop share price change the following day.</p>
<p>Here's a look at First Industrial Realty's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.67</td>
<td>0.64</td>
<td>0.62</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.68</td>
<td>0.66</td>
<td>0.60</td>
<td>0.63</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>166.83M</td>
<td>163.57M</td>
<td>159.62M</td>
<td>156.70M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>167.65M</td>
<td>164.14M</td>
<td>162.27M</td>
<td>157.28M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>First Industrial Realty management provided guidance for FY 2025, expecting earnings between $2.87 and $2.97 per share.</p>
<p>To track all earnings releases for First Industrial Realty <a href="https://www.benzinga.com/quote/FR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


First Industrial Realty Earnings Report: Q4 Overview

<p><strong>Accuray</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) released its Q2 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Accuray beat estimated earnings by 150.0%, reporting an EPS of $0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $8.94 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.01, leading to a 3.0% increase share price change the next day.</p>
<p>Here's a look at Accuray's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.05</td>
<td>0.03</td>
<td>-0.01</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.04</td>
<td>0.03</td>
<td>-0.06</td>
<td>-0.10</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>97.55M</td>
<td>121.51M</td>
<td>113.65M</td>
<td>106.67M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>101.55M</td>
<td>134.29M</td>
<td>101.13M</td>
<td>107.24M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Accuray <a href="https://www.benzinga.com/quote/ARAY/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ARAY

Accuray Q2 Earnings Summary & Key Takeaways

<p><strong>ASGN</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>ASGN beat estimated earnings by 6.0%, reporting an EPS of $1.28 versus an estimate of $1.21.</p>
<p>Revenue was down $89.00 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.07 in the last quarter, resulting in a 1.0% increase share price change the following day.</p>
<p>Here's a look at ASGN's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.36</td>
<td>1.33</td>
<td>1.11</td>
<td>1.37</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.43</td>
<td>1.36</td>
<td>1.16</td>
<td>1.45</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.03B</td>
<td>1.05B</td>
<td>1.04B</td>
<td>1.05B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.03B</td>
<td>1.03B</td>
<td>1.05B</td>
<td>1.07B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>ASGN management provided guidance for Q1 2025, expecting earnings between $0.91 and $0.97 per share.</p>
<p>To track all earnings releases for ASGN <a href="https://www.benzinga.com/quote/ASGN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ASGN

ASGN: Q4 Earnings Insights

<p>Matrix Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 11.11 percent decrease over losses of $(0.18) per share from the same period last year.  The company reported quarterly sales of $187.17 million which beat the analyst consensus estimate of $185.15 million by 1.09 percent.  This is a 6.93 percent increase over sales of $175.04 million the same period last year.</p>


MTRX

Matrix Service Q2 Adj EPS $(0.20) Beats $(0.22) Estimate, Sales $187.17M Beat $185.15M Estimate

<p><strong>Corteva</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:30 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Corteva beat estimated earnings by 3.0%, reporting an EPS of $0.32 versus an estimate of $0.31.</p>
<p>Revenue was up $271.00 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>During the previous quarter, the company missed on EPS by $0.19, leading to a 5.0% drop share price change the next day.</p>
<p>Here's a look at Corteva's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.30</td>
<td>1.73</td>
<td>0.84</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.49</td>
<td>1.83</td>
<td>0.89</td>
<td>0.15</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.70B</td>
<td>6.16B</td>
<td>4.65B</td>
<td>3.62B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.33B</td>
<td>6.11B</td>
<td>4.49B</td>
<td>3.71B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Corteva management provided guidance for FY 2025, expecting earnings between $2.7 and $2.95 per share.</p>
<p>To track all earnings releases for Corteva <a href="https://www.benzinga.com/quote/CTVA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CTVA

Earnings Breakdown: Corteva Q4

KIRK

Kirkland shares are trading higher after the company announced its shareholders approved the issuances of shares of common stock pursuant to the Term Loan Credit Agreement and Subscription Agreement previously entered into with Beyond

Comments

Nuveen Churchill Direct

Nuveen Churchill Direct (NCDL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga